According to the latest report by IMARC Group, titled “Immunoassay Market Report by Technology (Radioimmunoassay, Enzyme Immunoassay, Rapid Test, and Others), Product (Reagents and Kits, Analyzers/Instruments, Software and Services), Application (Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, and Others), End Use (Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical and Biotech Companies, Academic Research Centers, and Others), and Region 2025-2033,” the global immunoassay market reached a value of USD 32.6 Billion in 2024. Immunoassay (IA) is a biochemical technique used to measure the concentration or presence of macromolecules analytes in a solution through an antibody or an antigen. The immunoassay instruments help in detecting the concentration and presence of analytes in the blood, plasma and urine samples. It plays a crucial role in clinical diagnostics, pharmaceutical analysis, environmental monitoring, and security and finds application in research centers, hospitals, and laboratories.
Global Immunoassay Market Trends:
The rising cases of infectious diseases around the world are driving the growth of the market. Immunoassay has become an important part of the diagnostic regime for diseases, such as COVID-19, dengue, hepatitis, HIV, malaria, and tuberculosis. In addition to this, technological advancements in the field of immunoassays offering expedited results with higher efficacy, detection limits, sensitivity, and cost-efficiency are contributing to the market growth. The increasing adoption of rapid tests and point-of-care (PoC) testing for drug monitoring and alcohol abuse is acting as another major growth-inducing factor. Furthermore, growth in biotechnology and biopharmaceutical industries coupled with the emerging trend of smartphone-based formats and multiplex bead assays are creating a positive outlook for the market. Looking forward, the market value is projected to reach USD 51.5 Billion by 2033, expanding at a CAGR of 4.78% during 2025-2033.
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Technology, Product, Application, End Use, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Abbott, Becton Dickinson and Company, BioMérieux SA, Danaher Corporation, Merck KGaA, PerkinElmer Inc, Quidel Corporation, Siemens Healthcare Pty Ltd (Siemens AG), Sysmex Corporation and Thermo Fisher Scientific |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
Follow us on twitter: @imarcglobal